Streetbeat News

Earnings

SAGE

Sage Therapeutics reported Q3 losses of $(3.37) per share, a 45.89% decrease from the same period last year. The company's quarterly sales were $2.72 million, missing the analyst consensus estimate of $4.62 million by 41.21%. However, this is a 56.18% increase over sales of $1.74 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:34 am

SOPH

Sophia Genetics (NASDAQ:SOPH) reported Q3 2023 GAAP EPS of $(0.21), beating the estimate of $(0.31) by 32.26%. The company also reported quarterly sales of $16.30M, surpassing the estimate of $15.63M by 4.31%. Both figures represent significant increases from the same period last year.

Portfolio Pulse from saritha@benzinga.com

November 07, 2023 | 11:33 am

LQDA

Liquidia reported Q3 earnings per share (EPS) of $(0.24), compared to $(0.14) year over year (YoY). The company's sales were $3.68M, missing the estimate of $4.33M.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:33 am

RXO

RXO reported Q3 2023 earnings per share (EPS) of $0.05, beating the estimate of $0.01. The company's revenue was $1B, surpassing the estimate of $956.94M.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:33 am

PLNT

Planet Fitness reported Q3 adjusted earnings of $0.59 per share, beating the analyst consensus estimate of $0.55 by 7.27%. This is a 40.48% increase over earnings of $0.42 per share from the same period last year. The company also reported quarterly sales of $277.60 million, beating the analyst consensus estimate of $267.61 million by 3.73%. This is a 13.59% increase over sales of $244.39 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:33 am

DHI

D.R. Horton reported Q4 home sales revenues of $8.8B on 22,928 homes closed. The company also saw a 39% increase in net sales orders to 18,939 homes and a 34% increase in value to $7.3B.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:32 am

OB

Outbrain (NASDAQ:OB) reported Q3 earnings of $0.01 per share, beating the analyst consensus estimate of $(0.02) by 150 percent. However, the company's quarterly sales of $230.01 million missed the analyst consensus estimate of $241.67 million by 4.82 percent.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:32 am

INFU

InfuSystems Holdings reported Q3 earnings of $0.03 per share, meeting analyst consensus. This is a 50% increase from last year. The company also reported sales of $31.90 million, beating the analyst consensus of $30.77 million by 3.68%. This is a 16.94% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:31 am

FOR

Forestar Group reported Q4 earnings of $1.44 per share, beating the analyst consensus estimate of $0.94 by 53.19%. The company also reported quarterly sales of $549.70 million, surpassing the analyst consensus estimate of $399.05 million by 37.75%. Both earnings and sales have seen significant increases compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:31 am

VPG

Vishay Precision Group (NYSE:VPG) reported Q3 adjusted earnings of $0.47 per share, missing the analyst consensus estimate of $0.56 by 16.07%. This is a 31.88% decrease from the same period last year. The company also reported quarterly sales of $85.90 million, missing the analyst consensus estimate of $90.11 million by 4.67%. This is a 4.62% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:31 am